SPBC1683.03c Antibody

What is the SPBC1683.03c gene and what protein does it encode?

SPBC1683.03c is the systematic gene ID for sup11+ in Schizosaccharomyces pombe. It encodes Sup11p, a membrane protein that shows significant homology to Saccharomyces cerevisiae Kre9, which is involved in β-1,6-glucan synthesis. Sup11p is an essential protein required for proper cell wall formation, particularly β-1,6-glucan synthesis, and is indispensable for correct septum assembly . The protein resides in the late Golgi or post-Golgi compartments and contains a signal anchor sequence that orients the protein toward the lumen . Knockout studies have demonstrated that Sup11p is essential for cell viability, with depletion leading to severe morphological defects and malformation of the septum .

What are the typical applications for SPBC1683.03c (Sup11p) antibodies in fission yeast research?

Sup11p antibodies are valuable tools for several research applications:

• Protein localization studies: Immunofluorescence and immunogold electron microscopy to determine the subcellular localization of Sup11p in wild-type and mutant backgrounds .

• Protein expression analysis: Western blotting to monitor Sup11p expression levels, particularly in conditional mutants like nmt81-sup11 .

• Post-translational modification studies: Detecting glycosylation states of Sup11p, which is subject to O-mannosylation and, under certain conditions, N-glycosylation .

• Protein-protein interaction studies: Immunoprecipitation to identify interaction partners involved in β-1,6-glucan synthesis and cell wall formation.

• Phenotypic analysis correlation: Linking cell wall defects and septum malformation with Sup11p expression and localization .

How should I validate the specificity of a SPBC1683.03c antibody?

Antibody specificity validation is critical for reliable experimental results. A comprehensive validation approach should include:

• Whole proteome screening: Test the antibody against ~5,000 different fission yeast proteins deposited on microarrays to identify potential cross-reactivity with other proteins .

• Genetic controls: Use sup11+ deletion strains (with plasmid-based complementation due to its essential nature) as negative controls .

• Tagged protein controls: Compare detection patterns between antibodies raised against native Sup11p and epitope-tagged versions (like Sup11p:HA) .

• Western blot analysis: Confirm single band detection at the expected molecular weight (~50 kDa plus glycosylation) .

• Peptide competition assay: Pre-incubate the antibody with the immunizing peptide to confirm signal specificity.

Studies have shown that antibodies can cross-react with noncognate proteins to varying degrees, and these interactions cannot always be predicted by amino acid sequence alignment alone .

What post-translational modifications of Sup11p should be considered when selecting and using antibodies?

Sup11p undergoes significant post-translational modifications that can affect antibody recognition:

• O-mannosylation: Sup11p is a O-mannoprotein with extensive mannose modifications, particularly in S/T-rich regions .

• N-glycosylation: In certain mutant backgrounds (e.g., oma4 mutant), Sup11p can be N-glycosylated at an unusual N-X-A sequon that is normally masked by O-mannosylation .

• Membrane insertion: As a membrane protein with a signal anchor sequence, Sup11p's topology must be considered when selecting antibody epitopes .

When selecting antibodies, target epitopes that are not affected by these modifications or explicitly choose antibodies that can recognize the protein regardless of its glycosylation state.

What are the optimal fixation and permeabilization protocols for immunolocalization of SPBC1683.03c (Sup11p)?

For successful immunolocalization of Sup11p, consider the following methodological approach:

• Methanol fixation: Use cold methanol fixation at -20°C as demonstrated in the research, which preserves Golgi/post-Golgi structures while allowing antibody access .

• Alternative fixation methods: For co-localization with membrane structures, a combination of formaldehyde (3.7%) and glutaraldehyde (0.2%) may preserve membrane morphology better.

• Permeabilization considerations: Since Sup11p is a membrane protein with luminal orientation, ensure sufficient permeabilization to allow antibody access to the epitope.

• Specific protocol details:

  • Harvest cells in mid-logarithmic phase

  • Fix cells with cold methanol (-20°C) for 8 minutes

  • Wash 3× with PEM buffer (100 mM PIPES pH 6.9, 1 mM EGTA, 1 mM MgSO₄)

  • Permeabilize with 1% Triton X-100 in PEM for 30 seconds

  • Block with 1% BSA in PEMBAL for 30 minutes

  • Incubate with primary antibody (1:100-1:500 dilution) overnight at 4°C

  • Wash and apply appropriate secondary antibody

For immunogold electron microscopy, proper membrane preservation is crucial with specialized fixation combining 2% glutaraldehyde and 0.5% paraformaldehyde, followed by careful dehydration and embedding protocols .

How can I distinguish between membrane-associated and cell wall-associated forms of Sup11p?

Distinguishing between membrane-associated and potential cell wall-associated forms of Sup11p requires multiple complementary approaches:

• Subcellular fractionation: Use sucrose density gradient centrifugation to separate membrane compartments (ER, Golgi, plasma membrane) from cell wall fractions .

• Proteinase K protection assay: This technique can determine protein topology - Sup11p exhibits a luminal orientation protected from proteinase K digestion unless membranes are solubilized with detergent .

• Cell wall biotinylation: Surface proteins can be specifically labeled with biotin and purified to determine if any Sup11p is exposed at the cell surface .

• Comparative analysis with known markers: Co-staining with established markers for Golgi (Anp1), post-Golgi vesicles, and plasma membrane proteins helps determine the precise localization.

Research has shown that Sup11p primarily localizes to late Golgi or post-Golgi compartments rather than being incorporated into the cell wall itself, despite its role in β-1,6-glucan synthesis .

How does the genetic background affect antibody recognition of Sup11p?

Genetic background can significantly impact antibody recognition of Sup11p due to altered post-translational modifications:

• O-mannosylation mutants: In protein O-mannosyl transferase mutants (oma2, oma4), Sup11p shows reduced O-mannosylation, potentially exposing epitopes that are normally masked .

• N-glycosylation effects: In the oma4 mutant background, Sup11p can receive unusual N-glycosylation at an N-X-A sequon that is normally masked by O-mannosylation in wild type cells .

• Expression level variations: In conditional mutants like nmt81-sup11, reduced expression levels may affect detection sensitivity requirements .

When using Sup11p antibodies across different genetic backgrounds, include appropriate controls and consider the potential impact of these modifications on epitope accessibility.

What are the technical challenges in analyzing Sup11p's role in β-1,6-glucan synthesis using antibody-based approaches?

Investigating Sup11p's role in β-1,6-glucan synthesis presents several technical challenges:

• Temporal-spatial coordination: Sup11p acts in the secretory pathway while β-1,6-glucan is assembled in the cell wall, making direct observation of the process difficult.

• Protein complex detection: Sup11p likely functions in protein complexes with other β-1,6-glucan synthesis factors, requiring careful immunoprecipitation conditions to maintain these interactions.

• Distinguishing direct vs. indirect effects: Since Sup11p depletion leads to multiple cellular defects, including transcriptional changes in cell wall enzymes, correlating antibody-detected Sup11p levels with specific β-1,6-glucan synthesis steps requires careful experimental design .

• Substrate accessibility: Studying the interaction between Sup11p and its putative substrates may require specialized membrane solubilization protocols that maintain protein activity.

Research has shown that Sup11p depletion induces significant cell wall remodeling processes and affects the expression of many glucanases and glucan synthesis enzymes, requiring multiparameter analysis to distinguish primary from secondary effects .

How can I optimize immunoprecipitation protocols for studying Sup11p interaction partners?

For successful immunoprecipitation of Sup11p and its interaction partners:

• Membrane protein considerations:

  • Use mild detergents (1% digitonin or 0.5% NP-40) to solubilize membranes while preserving protein-protein interactions

  • Include protease inhibitors and maintain sample at 4°C throughout the procedure

  • Consider crosslinking with DSP (dithiobis[succinimidyl propionate]) before lysis to stabilize transient interactions

• Buffer optimization:

  • Use buffers containing 10% glycerol to stabilize membrane proteins

  • Adjust salt concentration (150-300 mM NaCl) to balance specific vs. non-specific interactions

  • Include reducing agents (1-5 mM DTT) to prevent oxidation of cysteine residues

• Antibody considerations:

  • Compare results using antibodies targeting different epitopes of Sup11p

  • Consider using HA-tagged Sup11p and anti-HA antibodies, which have been successfully used in research

  • Pre-clear lysates with protein A/G beads to reduce non-specific binding

• Validation approaches:

  • Perform reciprocal IPs using antibodies against predicted interaction partners

  • Include appropriate controls (non-specific IgG, lysates from cells lacking Sup11p)

  • Confirm interactions using orthogonal methods (proximity labeling, yeast two-hybrid)

Given Sup11p's genetic interactions with β-1,6-glucanase family members, these would be prime candidates to investigate as potential physical interaction partners .

How can Sup11p antibodies be used to study the relationship between β-1,6-glucan synthesis and septum formation?

To investigate the relationship between Sup11p-mediated β-1,6-glucan synthesis and septum formation:

• Time-course experiments: Use synchronized cultures and collect samples at different cell cycle stages for immunostaining with Sup11p antibodies and septum markers .

• Co-localization studies: Perform double immunostaining with Sup11p antibodies and septum-specific markers (Bgs1p, Ags1p) to determine temporal-spatial relationships .

• Mutant analysis approach: Compare Sup11p localization in wild-type cells versus mutants with septum formation defects (e.g., SIN pathway mutants).

• Quantitative analysis: Measure Sup11p levels and distribution during septum formation using quantitative immunofluorescence microscopy.

Research has demonstrated that Sup11p is indispensable for proper septum assembly, with depletion leading to severe septum malformation and accumulation of cell wall material at the center of the closing septum . The septum defects in nmt81-sup11 mutants include abnormal deposition of β-1,3-glucan, which should normally be restricted to the primary septum .

What controls should be included when using Sup11p antibodies for Western blotting?

For reliable Western blot analysis of Sup11p, include the following controls:

• Positive control: Lysate from wild-type cells expressing normal levels of Sup11p .

• Negative control: Where possible, lysate from a sup11+ repression strain (e.g., nmt81-sup11 under repressive conditions) .

• Loading control: Probing for a housekeeping protein of similar abundance (e.g., GAPDH) or total protein staining (Ponceau S).

• Glycosylation controls:

  • EndoH-treated samples to remove N-glycans

  • Samples from O-mannosylation mutants (oma2, oma4) to assess impact of O-mannosylation on detection

• Size marker: A tagged version of Sup11p (e.g., Sup11p:HA) with known molecular weight shift .

How can Sup11p antibodies help resolve conflicting data about cell wall architecture in fission yeast?

Sup11p antibodies can be valuable tools to address conflicting data about fission yeast cell wall architecture:

• Layer-specific localization: By combining Sup11p immunogold labeling with cell wall component-specific staining, researchers can map the spatial relationship between β-1,6-glucan synthesis machinery and other wall components .

• Developmental analysis: Compare Sup11p localization during different growth phases and cell cycle stages to understand temporal regulation of cell wall synthesis.

• Comparative mutant analysis: Analyze Sup11p localization and β-1,6-glucan production in various cell wall mutants to establish dependency relationships.

• Biochemical correlation: Correlate Sup11p levels (by quantitative Western blotting) with β-1,6-glucan content (by specialized cell wall fractionation techniques) across different conditions.

The research shows that immunogold labeling studies have revealed that β-1,6-glucan is located directly underneath the outer electron-dense layer, linking α-galactomannan to the glucan matrix . This placement is critical for understanding the layered architecture of the fission yeast cell wall, which from inside to outside consists of: plasma membrane, β-1,3-glucan, β-1,6-branched β-1,3-glucan, and mannoproteins as the outermost layer .

What are common pitfalls when using SPBC1683.03c antibodies and how can they be addressed?

When working with Sup11p antibodies, researchers should be aware of these potential pitfalls:

• Cross-reactivity issues: Antibodies may recognize other yeast proteins to varying degrees beyond their cognate targets . Address by:

  • Validating antibody specificity using whole proteome microarrays where available

  • Including appropriate negative controls (sup11+ depletion strains)

  • Using multiple antibodies targeting different epitopes of Sup11p

• Post-translational modification interference: Extensive O-mannosylation may mask epitopes. Address by:

  • Selecting antibodies raised against peptides from regions with minimal glycosylation

  • Testing antibody reactivity in wild-type vs. O-mannosylation mutants

  • Using deglycosylation treatments before antibody application

• Subcellular localization challenges: As a membrane protein in the secretory pathway, Sup11p detection requires careful sample preparation. Address by:

  • Optimizing fixation and permeabilization protocols for immunofluorescence

  • Using gentle cell lysis methods to preserve membrane structure

  • Including appropriate markers for subcellular compartments

• Expression level variations: Sup11p expression may vary with cell cycle or growth conditions. Address by:

  • Standardizing culture conditions and harvesting methods

  • Using quantitative Western blotting with appropriate loading controls

  • Including time-course analysis when relevant

How can I adapt immunofluorescence protocols to simultaneously detect Sup11p and cell wall components?

For simultaneous detection of Sup11p and cell wall components:

• Sequential labeling approach:

  • First perform methanol fixation and immunolabeling of Sup11p

  • Follow with mild cell wall digestion if needed for antibody penetration

  • Complete with cell wall component staining (e.g., aniline blue for β-1,3-glucan)

• Specific methodological considerations:

  • Use Aniline blue (0.1%) for β-1,3-glucan visualization

  • Apply specialized antibodies against β-1,6-glucan where available

  • Consider calcofluor white staining for general cell wall visualization

  • Optimize antibody concentrations to achieve balanced signal intensity

• Advanced imaging techniques:

  • Use deconvolution microscopy to improve resolution of closely associated structures

  • Apply structured illumination microscopy (SIM) for super-resolution imaging

  • Consider 3D reconstruction from z-stack images to visualize spatial relationships

• Controls and validation:

  • Include single-labeled samples to verify specificity of each detection channel

  • Use mutants with known cell wall defects as controls

  • Perform parallel electron microscopy studies for ultrastructural correlation

Research has shown that in Sup11p-depleted cells, β-1,3-glucan partitioning is altered in both the septum and lateral cell wall, making co-detection particularly informative .

What experimental design would best elucidate the functional relationship between Sup11p and the genes identified in transcriptome analyses?

To investigate the functional relationship between Sup11p and genes identified in transcriptome analyses:

• Hierarchical genetic analysis:

  • Create double mutants between conditional sup11 mutants and deletion mutants of upregulated/downregulated genes

  • Analyze genetic interactions (synthetic lethality, suppression, or enhancement)

  • Focus on interactions with β-1,6-glucanase family members, which have shown genetic interactions with sup11+

• Protein-level correlation studies:

  • Use Sup11p antibodies alongside antibodies against products of differentially expressed genes

  • Perform co-immunoprecipitation to test for physical interactions

  • Analyze co-localization using dual immunofluorescence

• Temporal expression analysis:

  • Compare the timing of Sup11p protein expression with transcriptional changes using time-course experiments

  • Use quantitative Western blotting (Sup11p) combined with RT-qPCR (target genes)

• Mechanistic integration:

  • Focus on the 54 genes showing significant dysregulation in the nmt81-sup11 mutant

  • Pay particular attention to the β-1,3-glucanosyl-transferase Gas2p, which plays a crucial role in the accumulation of septum material in Sup11p-depleted cells

Transcriptome analysis of the nmt81-sup11 mutant identified significant regulation of several cell wall glucan-modifying enzymes, suggesting a complex regulatory network connecting Sup11p function to broader cell wall maintenance systems .

How might advanced microscopy techniques enhance the utility of Sup11p antibodies in cell wall research?

Advanced microscopy techniques can significantly enhance Sup11p antibody applications:

• Super-resolution microscopy approaches:

  • Stimulated emission depletion (STED) microscopy to resolve Sup11p localization within the Golgi with <50 nm resolution

  • Single-molecule localization microscopy (PALM/STORM) to track individual Sup11p molecules

  • Structured illumination microscopy (SIM) for 3D visualization of Sup11p distribution relative to cell wall synthesis machinery

• Live-cell imaging adaptations:

  • Combine Sup11p antibody fragments with cell-penetrating peptides for live-cell applications

  • Correlate with fluorescently tagged cell wall synthesis components

  • Develop split-GFP complementation systems to visualize Sup11p interactions in vivo

• Correlative light and electron microscopy (CLEM):

  • Use Sup11p antibodies with both fluorescent and gold labels

  • Precisely correlate light microscopy localization with ultrastructural features

  • Further refine understanding of Sup11p's role in connecting secretory pathway to cell wall synthesis

• Expansion microscopy potential:

  • Apply physical expansion of fixed samples to achieve super-resolution with standard confocal microscopy

  • Enhance visualization of Sup11p distribution relative to cell wall architecture

These advanced techniques could help resolve the precise subcellular localization of Sup11p, which has been challenging with conventional methods despite evidence placing it in the late Golgi or post-Golgi compartments .

What are promising research directions for understanding the mechanistic role of Sup11p in β-1,6-glucan synthesis?

Future research into Sup11p's mechanistic role should consider:

• Structural biology approaches:

  • Develop antibodies against specific structural domains of Sup11p

  • Use these domain-specific antibodies to correlate structure with function

  • Apply cryo-electron microscopy to visualize Sup11p complexes

• In vitro reconstitution experiments:

  • Purify Sup11p using antibody-based affinity chromatography

  • Attempt in vitro β-1,6-glucan synthesis with purified components

  • Identify direct interaction partners and substrates

• Systems biology integration:

  • Combine proteomics, glycomics, and transcriptomics data

  • Map the complete network of proteins involved in β-1,6-glucan synthesis

  • Use Sup11p antibodies to validate computational predictions

• Comparative studies across fungi:

  • Develop antibodies against homologs like S. cerevisiae Kre9

  • Compare localization, interactions, and function across species

  • Identify conserved and divergent aspects of β-1,6-glucan synthesis mechanisms